Status:

COMPLETED

Chest Wall Oscillation for Asthma and COPD Exacerbations Trial (COAT)

Lead Sponsor:

University of Chicago

Collaborating Sponsors:

Hill-Rom

Conditions:

Asthma

Chronic Obstructive Pulmonary Disease (COPD)

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The objective of this study was to evaluate the use of high frequency chest wall oscillation (HFCWO) early in the treatment of adults hospitalized for acute asthma or chronic obstructive pulmonary dis...

Detailed Description

Acute asthma and chronic obstructive pulmonary disease (COPD) are exceedingly common, which together account for nearly 1 million hospitalizations each year in the United States alone. Beta agonists, ...

Eligibility Criteria

Inclusion

  • Age 18 years and older
  • Admission to the inpatient medical service
  • Physician-diagnosed asthma or asthma/COPD or COPD exacerbation.
  • Evidence of airflow obstruction on spirometry

Exclusion

  • More than 24 hours since admission to the inpatient medical service
  • Admission to an intensive care unit
  • Hospital discharge planned within the next 24 hours
  • Other chronic respiratory disease (e.g., sarcoidosis, idiopathic pulmonary fibrosis)
  • Chest wall abnormalities (e.g., severe kyphoscoliosis) that precludes using the vest
  • Chest wall or abdominal trauma/surgery in the past 6 weeks that precludes using the vest
  • Physician declines to provide consent
  • Patient unable (e.g., history of cognitive impairment, unable to understand English) or declines to provide consent
  • Previous participant in this study
  • Corticosteroid therapy (prednisone \>0 mg/d equivalent) for \>1 week prior to admission

Key Trial Info

Start Date :

October 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2008

Estimated Enrollment :

52 Patients enrolled

Trial Details

Trial ID

NCT00181285

Start Date

October 1 2003

End Date

May 1 2008

Last Update

August 8 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Mercy Hospital and Medical Center

Chicago, Illinois, United States, 60616